134 related articles for article (PubMed ID: 9614382)
1. Hyaluronate binding assay study of transfected CD44 V4-V7 isoforms into the human gastric carcinoma cell line SC-M1.
Harn HJ; Shen KL; Liu CA; Ho LI; Yang LS; Yueh KC
J Pathol; 1998 Mar; 184(3):291-6. PubMed ID: 9614382
[TBL] [Abstract][Full Text] [Related]
2. CD44 isoforms containing exons V6 and V7 are differentially expressed on mitogenically stimulated normal and Epstein-Barr virus-transformed human B cells.
Kryworuckho M; Diaz-Mitoma F; Kumar A
Immunology; 1995 Sep; 86(1):41-8. PubMed ID: 7590880
[TBL] [Abstract][Full Text] [Related]
3. Expression of CD44 standard and variant isoforms v5, v6 and v7 in human ovarian cancer cell lines.
Stickeler E; Runnebaum IB; Möbus VJ; Kieback DG; Kreienberg R
Anticancer Res; 1997; 17(3C):1871-6. PubMed ID: 9216637
[TBL] [Abstract][Full Text] [Related]
4. Involvement of CD44 variant isoforms in hyaluronate adhesion by human activated T cells.
Galluzzo E; Albi N; Fiorucci S; Merigiola C; Ruggeri L; Tosti A; Grossi CE; Velardi A
Eur J Immunol; 1995 Oct; 25(10):2932-9. PubMed ID: 7589094
[TBL] [Abstract][Full Text] [Related]
5. Functional heterogeneity of CD44 molecules in ovarian cancer cell lines.
Cannistra SA; DeFranzo B; Niloff J; Ottensmeir C
Clin Cancer Res; 1995 Mar; 1(3):333-42. PubMed ID: 9815989
[TBL] [Abstract][Full Text] [Related]
6. Metastasis suppression by the standard CD44 isoform does not require the binding of prostate cancer cells to hyaluronate.
Gao AC; Lou W; Sleeman JP; Isaacs JT
Cancer Res; 1998 Jun; 58(11):2350-2. PubMed ID: 9622073
[TBL] [Abstract][Full Text] [Related]
7. Expression of antisense CD44 variant 6 inhibits colorectal tumor metastasis and tumor growth in a wound environment.
Reeder JA; Gotley DC; Walsh MD; Fawcett J; Antalis TM
Cancer Res; 1998 Aug; 58(16):3719-26. PubMed ID: 9721884
[TBL] [Abstract][Full Text] [Related]
8. Serum assay of soluble CD44 standard (sCD44-st), CD44 splice variant v5 (sCD44-v5), and CD44 splice variant v6 (sCD44-v6) in patients with epithelial ovarian cancer.
Gadducci A; Ferdeghini M; Fanucchi A; Annicchiarico C; Cosio S; Prontera C; Bianchi R; Genazzani AR
Anticancer Res; 1997; 17(6D):4463-6. PubMed ID: 9494551
[TBL] [Abstract][Full Text] [Related]
9. Adhesive and/or signaling functions of CD44 isoforms in human dendritic cells.
Haegel-Kronenberger H; de la Salle H; Bohbot A; Oberling F; Cazenave JP; Hanau D
J Immunol; 1998 Oct; 161(8):3902-11. PubMed ID: 9780156
[TBL] [Abstract][Full Text] [Related]
10. Human mast cells express the hyaluronic-acid-binding isoform of CD44 and adhere to hyaluronic acid.
Fukui M; Whittlesey K; Metcalfe DD; Dastych J
Clin Immunol; 2000 Mar; 94(3):173-8. PubMed ID: 10692236
[TBL] [Abstract][Full Text] [Related]
11. Quantitative assessment of expression of cell adhesion molecule (CD44) splice variants: CD44 standard (CD44s) and v5, v6 isoforms in oral leukoplakias: an immunohistochemical study.
Godge PY; Poonja LS
Indian J Dent Res; 2011; 22(3):493-4. PubMed ID: 22048598
[TBL] [Abstract][Full Text] [Related]
12. Hyaluronate-independent metastatic behavior of CD44 variant-expressing pancreatic carcinoma cells.
Sleeman JP; Arming S; Moll JF; Hekele A; Rudy W; Sherman LS; Kreil G; Ponta H; Herrlich P
Cancer Res; 1996 Jul; 56(13):3134-41. PubMed ID: 8674073
[TBL] [Abstract][Full Text] [Related]
13. Differential expression of the human metastasis adhesion molecule CD44V in normal and carcinomatous stomach mucosa of Chinese subjects.
Harn HJ; Ho LI; Chang JY; Wu CW; Jiang SY; Lee HS; Lee WH
Cancer; 1995 Mar; 75(5):1065-71. PubMed ID: 7531611
[TBL] [Abstract][Full Text] [Related]
14. Hyaluronate and its receptors in bone marrow.
Schade UM; Nehmann N; Horny HP; Prehm P; Delpech B; Krüger WH; Zander AR; Schumacher U
Acta Histochem; 2006; 108(2):141-7. PubMed ID: 16713618
[TBL] [Abstract][Full Text] [Related]
15. O-linked glycosylation modifies CD44 adhesion to hyaluronate in colon carcinoma cells.
Dasgupta A; Takahashi K; Cutler M; Tanabe KK
Biochem Biophys Res Commun; 1996 Oct; 227(1):110-7. PubMed ID: 8858111
[TBL] [Abstract][Full Text] [Related]
16. Osteopontin promotes integrin activation through outside-in and inside-out mechanisms: OPN-CD44V interaction enhances survival in gastrointestinal cancer cells.
Lee JL; Wang MJ; Sudhir PR; Chen GD; Chi CW; Chen JY
Cancer Res; 2007 Mar; 67(5):2089-97. PubMed ID: 17332338
[TBL] [Abstract][Full Text] [Related]
17. Effects of anti-CD44 monoclonal antibody on adhesion of erythroid leukemic cells (ELM-I-1) to hematopoietic supportive cells (MS-5): CD44, but not hyaluronate-mediated, cell-cell adhesion.
Sugimoto K; Tsurumaki Y; Hoshi H; Kadowaki S; LeBousse-Kerdiles MC; Smadja-Joffe F; Mori KJ
Exp Hematol; 1994 Jun; 22(6):488-94. PubMed ID: 7514542
[TBL] [Abstract][Full Text] [Related]
18. Expression of hyaluronan receptors CD44 and RHAMM in stomach cancers: relevance with tumor progression.
Li H; Guo L; Li JW; Liu N; Qi R; Liu J
Int J Oncol; 2000 Nov; 17(5):927-32. PubMed ID: 11029494
[TBL] [Abstract][Full Text] [Related]
19. CD44 in normal human pancreas and pancreatic carcinoma cell lines.
Ringel J; Jesnowski R; Schmidt C; Ringel J; Köhler HJ; Rychly J; Batra SK; Löhr M
Teratog Carcinog Mutagen; 2001; 21(1):97-106. PubMed ID: 11135324
[TBL] [Abstract][Full Text] [Related]
20. Expression of CD44 in duct cell carcinomas and in intraductal neoplasms of the pancreas.
Satoh K; Shimosegawa T; Koizumi M; Toyota T
Anticancer Res; 1997; 17(1A):215-9. PubMed ID: 9066654
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]